Table 2 Clinical and laboratorial data of sample before and after the therapeutic intervention, separated by gender.
From: Effect of the carbohydrate counting method on glycemic control in patients with type 1 diabetes
Variables | Men | Women | ||||
|---|---|---|---|---|---|---|
Baseline | 3 months | Significance Level (p) | Baseline | 3 months | Significance level (p) | |
n (number) | 19 | 19 | 32 | 32 | ||
Duration of diabetes (years) | 9,24 ± 1,41 | 9,24 ± 1,41 | 0,124 | 12,34 ± 1,48 | 12,34 ± 1,48 | 0,167 |
BMI (kg/m2) | 22,55 ± 0,62 | 22,88 ± 0,65 | 0,37 | 23,0 ± 0,57 | 23,0 ± 0,65 | 0,47 |
sBP (mmHg) | 120 ± 0,75 | 110 ± 1,78 | 0,58 | 100,82 ± 0,29 | 110 ± 0,38 | 0,33 |
sDP(mmHg) | 70,67 ± 1,23 | 70,75 ± 1,28 | 60,95 ± 1,04 | 90,59 ± 12,40 | ||
A1c (%) | 10,28 ± 0,55 | 9,30 ± 0,50 | 0,01 | 10,00 ± 2,42 | 9,65 ± 2,45 | 0,00 |
Cholesterol(mg/dl) | 159,63 ± 6,37 | 163,73 ± 5,70 | 0,164 | 183 ± 7,69 | 179,56 | 0,48 |
HDL- Cholesterol(mg/dl) | 50,63 ± 3,63 | 49,18 ± 4,07 | 0,46 | 55,7 ± 2,19 | 55,90 ± 1,77 | 0,92 |
LDL- Cholesterol (mg/dl) | 193,71 ± 7,86 | 184,41 ± 6,13 | 0,13 | 220,59 ± 8,00 | 213,59 ± 6,13 | 0,32 |
Triglycerides (mg/dl) | 89,73 ± 11,18 | 96,68 ± 14,25 | 0,49 | 95,31 ± 10,2 | 109 ± 14,15 | 0,09 |
Fasting blood sugar- (mg/dl) | 153,84 ± 28,37 | 153,84 ± 28,37 | 0,74 | 200,34 ± 20,32 | 171,12 ± 18,85 | 0,25 |
Postprandial glycemia (mg/dl) | 213,05 ± 16,83 | 231,47 ± 20,64 | 0,46 | 282 ± 16,32 | 250,46 ± 22,44 | 0,19 |
Insulin dose/kg | 0,89 ± 0,31 | 1,05 ± 0,31 | 0,00 | 1,07 ± 0,53 | 1,13 ± 0,49 | 0,10 |
NPH insulin dose | 55,22 ± 19,90 | 56,89 ± 18,52 | 0,16 | 55,00 ± 23,91 | 54,22 ± 22,65 | 0,40 |
Rapid insulin dose | 3,65 ± 5,30 | 3,12 ± 2,34 | 0,67 | 4,84 ± 10,17 | 12,13 ± 7,77 | 0,00 |